๐ฐ Iagnostics News
Page 33 - Iagnostics News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Iagnostics. Real-time updates on events, politics, business and more.
April 17, 2023
$16 Million Investment Led by Oxford Science Enterprises and Joined by Multiple Institutional Investors OXFORD, England, April 17, 2023 /PRNewswire/ -- Caristo Diagnostics Limited, a global
April 16, 2023
Groundbreaking RNA sequencing platform sheds light on complex genetic conditions and the future of precision diagnostics.
April 14, 2023
Dublin, April 14, 2023 (GLOBE NEWSWIRE) -- The "Brain Monitoring Market, By Product Type, By Application, By End User, and By Geography - Size, Share,...
April 14, 2023
Oxford Nanopore Technologies plc (LSE: ONT) ("Oxford Nanopore"), the company delivering a new generation of nanopore-based molecular sensing technology, and bioMérieux SA, a world leader in the field
April 13, 2023
For investors in hospital stocks, Khemka says the right time for entry is when the company has completed its capex, because the downside potential from that level is less, while the upside is good.
April 13, 2023
Dublin, April 13, 2023 (GLOBE NEWSWIRE) -- The "Clinical Diagnostic Market, By Test, By Product, By End User, and By Geography - Size, Share, Outlook,...
April 12, 2023
NORTHAMPTON, MA / ACCESSWIRE / April 12, 2023 / Quest Diagnostics "Being an employer of of choice is about the entire package-the right fit, competitive compensation and relevant benefits, and a culture
April 12, 2023
Renalytix PLC - London-based kidney health-focused diagnostics company - Says that two scientific presentations proving the utility of KidneyIntelX in minorities and veterans have been accepted at... | April 12, 2023
April 12, 2023
Function Oncology goes beyond next-generation sequencing with a CRISPR-based technology that identifies targets for a patientโs cancer regardless of whether or not they are mutated. Now out of stealth, the company will present data validating its approach during the American Association for Cancer Research annual meeting.